| scholarly article | Q13442814 |
| P50 | author | Brian A. Bruckner | Q91432122 |
| Matthias Loebe | Q114312358 | ||
| P2093 | author name string | Erik E Suarez | |
| Limael E Rodriguez | |||
| P2860 | cites work | Ventricular assist devices: pharmacological aspects of a mechanical therapy | Q27002612 |
| Third-generation blood pumps with mechanical noncontact magnetic bearings | Q28239089 | ||
| Use of a continuous-flow device in patients awaiting heart transplantation | Q28244009 | ||
| Clinical management of continuous-flow left ventricular assist devices in advanced heart failure | Q28274149 | ||
| Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects | Q34023163 | ||
| Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 | ||
| NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial | Q34362624 | ||
| Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device | Q35597572 | ||
| The HeartMate left ventricular assist system. Overview and 12-year experience | Q35665513 | ||
| Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy | Q37774034 | ||
| A review of clinical ventricular assist devices | Q37888289 | ||
| Current trends in implantable left ventricular assist devices | Q37913070 | ||
| Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure | Q37979986 | ||
| Total artificial heart and physical therapy management. | Q40840642 | ||
| First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report | Q40935982 | ||
| The physics of blood flow in capillaries. I. The nature of the motion | Q42085524 | ||
| Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. | Q43283940 | ||
| Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices | Q43790057 | ||
| European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system | Q44426077 | ||
| Low thromboembolic risk for patients with the Heartmate II left ventricular assist device | Q46233006 | ||
| Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. | Q47195643 | ||
| Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation | Q47291778 | ||
| Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation | Q47630614 | ||
| Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. | Q48310222 | ||
| End-organ function during chronic nonpulsatile circulation | Q48459862 | ||
| Advanced heart failure treated with continuous-flow left ventricular assist device | Q48952442 | ||
| Design features, developmental status, and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor. | Q50999560 | ||
| Design concepts and principle of operation of the HeartWare ventricular assist system. | Q51688455 | ||
| Implantable left ventricular assist devices. | Q53566322 | ||
| Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study | Q73492749 | ||
| The Heartmate II: design and development of a fully sealed axial flow left ventricular assist system | Q74013558 | ||
| Electromagnetic interference with a bipolar pacemaker by an induction heating (IH) rice cooker | Q83398219 | ||
| Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients | Q83582538 | ||
| Third-generation continuous flow left ventricular assist devices | Q83717038 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 32-37 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Methodist DeBakey cardiovascular journal | Q26841947 |
| P1476 | title | Ventricular assist devices (VAD) therapy: new technology, new hope? | |
| P478 | volume | 9 |
| Q47097098 | Advancements in mechanical circulatory support for patients in acute and chronic heart failure |
| Q64229620 | Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations |
| Q98726641 | Comprehensive review of hemolysis in ventricular assist devices |
| Q100401369 | Continuous-flow left ventricular assist devices: Management in the emergency department |
| Q35726089 | Left ventricular assist devices: a kidney's perspective |
| Q39196492 | Nanomaterials for Cardiac Myocyte Tissue Engineering |
| Q34371185 | Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center. |
| Q38635708 | QRS complex fragmentation and survival following left ventricular assist device implantation |
| Q38192515 | The practical role of echocardiography in selection, implantation, and management of patients requiring LVAD therapy |
Search more.